The Latest
-
Medtronic confirms paclitaxel balloon’s efficacy in post-approval trial
The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.
-
Boston Scientific plans $88.5M R&D expansion in Ireland
The device maker plans to invest 75 million euros into expanding the site, with a focus on cardiovascular innovation.
-
AIP to acquire Avanos Medical in $1.27B go-private deal
Avanos Medical generated $701.2 million last year from sectors where it competes with Boston Scientific, Medtronic and Stryker.
-
Stereotaxis to buy Robocath for up to $45M
The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening the company’s position in endovascular surgery, said CEO David Fischel.
-
Deep Dive
One year in: How medtech companies are coping with tariff challenges
A resilient medtech industry navigating the fallout from President Donald Trump’s trade wars is taking proactive steps to manage tariff costs as the administration’s policies continue to evolve.
-
CBP preps tariff refund portal for April 20 launch
The system will go live at 8 a.m. EDT to begin the electronic returns process for an estimated $127 billion in tariffs, the agency said Tuesday.
-
J&J’s cardiovascular unit stands out again in Q1
Johnson & Johnson’s strategic shift to higher growth medical device markets like cardiovascular is paying off, as the business was the only medtech unit to grow by double digits in the first quarter.
-
Stryker to buy Amplitude Vascular Systems
Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.
-
Medline recalls angiographic syringes, receives FDA warning letter
The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds.
-
GE HealthCare integrates ultrasound into Medtronic’s Stealth AXiS surgical system
Partnering with GE HealthCare has enabled Medtronic to provide live images to help surgeons assess mid-procedure changes.
-
Stryker is fully operational after cyberattack
The company disclosed that it expects a material impact on first-quarter financial results. However, it does not expect an effect on full-year results.
-
Pulse Biosciences hires Liane Teplitsky as COO
The appointment gives a former Abbott leader oversight of efforts to bring a pulsed field ablation device to market.